Cardio Diagnostics Holdings Inc. Common stock
Symbol: CDIO (NASDAQ)
Company Description:
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
- Today's Open: $4.23
- Today's High: $4.54
- Today's Low: $4.12
- Today's Volume: 26.80K
- Yesterday Close: $4.345
- Yesterday High: $4.56
- Yesterday Low: $4.33
- Yesterday Volume: 47.55K
- Last Min Volume: 1
- Last Min High: $4.265
- Last Min Low: $4.265
- Last Min VWAP: $4.265
- Name: Cardio Diagnostics Holdings Inc. Common stock
- Website: https://www.cdio.ai
- Listed Date: 2022-10-26
- Location: CHICAGO, IL
- Market Status: Active
- CIK Number: 0001870144
- SIC Code: 2835
- SIC description: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
- Market Cap: $7.66M
- Round Lot: 100
- Outstanding Shares: 1.76M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-15 | 8-K | View |
| 2025-10-03 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-10-03 | 4 | View |
| 2025-09-23 | 424B3 | View |
| 2025-09-19 | EFFECT | View |
| 2025-09-16 | POS AM | View |
| 2025-09-12 | 424B3 | View |
| 2025-09-09 | EFFECT | View |
| 2025-09-05 | POS AM | View |
| 2025-09-04 | DEFA14A | View |
| 2025-09-04 | DEF 14A | View |
| 2025-08-27 | ARS | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-13 | PRE 14A | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |